Production (Stage)
Bellicum Pharmaceuticals, Inc.
BLCM
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.26% | -51.89% | -29.47% | -24.06% | -13.30% |
| Total Receivables | -- | -- | -- | -- | 378.47% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -29.03% | -28.70% | -7.03% | 30.07% | -11.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.40% | -49.45% | -27.58% | -23.88% | -14.54% |
|
|
|||||
| Total Current Assets | -21.40% | -49.45% | -27.58% | -23.88% | -14.54% |
| Net Property, Plant & Equipment | -76.19% | -12.50% | 9.09% | 29.41% | -5.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -21.53% | -49.40% | -27.55% | -23.85% | -14.54% |
|
|
|||||
| Total Accounts Payable | 11.44% | -61.50% | 152.26% | -31.93% | 78.95% |
| Total Accrued Expenses | -51.55% | -23.59% | 31.41% | -19.79% | 37.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -0.96% | 122.55% | -70.95% | -58.43% | 3.13% |
| Total Other Current Liabilities | -0.96% | 122.55% | -70.95% | -58.43% | 3.13% |
| Total Current Liabilities | -35.41% | -26.17% | 25.03% | -34.38% | 26.86% |
|
|
|||||
| Total Current Liabilities | -35.41% | -26.17% | 25.03% | -34.38% | 26.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -35.41% | -26.17% | 25.03% | -34.38% | 26.86% |
|
|
|||||
| Common Stock & APIC | -0.77% | -0.77% | -0.68% | 0.12% | 0.12% |
| Retained Earnings | -0.13% | -1.26% | -1.40% | -1.09% | -1.28% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | -0.02% | -0.19% |
| Total Common Equity | -23.69% | -117.96% | -597.27% | -73.13% | -46.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 16.71% | 20.06% | 25.11% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 16.71% | 20.06% | 25.11% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -23.69% | -117.96% | -597.27% | -73.13% | -46.58% |
| Total Preferred Equity | 16.71% | 20.06% | 25.11% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.32% | -58.14% | -37.44% | -21.48% | -20.38% |
|
|
|||||